Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules
- PMID: 16873022
- DOI: 10.1016/j.chembiol.2006.05.011
Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules
Abstract
bZip and bHLHZip protein family members comprise a large fraction of eukaryotic transcription factors and need to bind DNA in order to exert most of their fundamental biological roles. Their binding to DNA requires homo- or heterodimerization via alpha-helical domains, which generally do not contain obvious binding sites for small molecules. We have identified two small molecules, dubbed Mycro1 and Mycro2, which inhibit the protein-protein interactions between the bHLHZip proteins c-Myc and Max. Mycros are the first inhibitors of c-Myc/Max dimerization, which have been demonstrated to inhibit DNA binding of c-Myc with preference over other dimeric transcription factors in vitro. Mycros inhibit c-Myc-dependent proliferation, gene transcription, and oncogenic transformation in the low micromolar concentration range. Our data support the idea that dimeric transcription factors can be druggable even in the absence of obvious small-molecule binding pockets.
Similar articles
-
Small-molecule perturbation of competing interactions between c-Myc and Max.Bioorg Med Chem Lett. 2009 Feb 1;19(3):807-10. doi: 10.1016/j.bmcl.2008.12.025. Epub 2008 Dec 10. Bioorg Med Chem Lett. 2009. PMID: 19114306
-
DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.Biol Chem. 1999 Sep;380(9):1121-6. doi: 10.1515/BC.1999.140. Biol Chem. 1999. PMID: 10543451
-
Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.J Mol Biol. 1998 Aug 7;281(1):165-81. doi: 10.1006/jmbi.1998.1914. J Mol Biol. 1998. PMID: 9680483
-
Function of the c-Myc oncogenic transcription factor.Exp Cell Res. 1999 Nov 25;253(1):63-77. doi: 10.1006/excr.1999.4686. Exp Cell Res. 1999. PMID: 10579912 Review.
-
The MAX-interacting transcription factor network.Semin Cancer Biol. 2006 Aug;16(4):265-74. doi: 10.1016/j.semcancer.2006.07.009. Epub 2006 Jul 14. Semin Cancer Biol. 2006. PMID: 16908182 Review.
Cited by
-
The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival.Cancers (Basel). 2023 Nov 21;15(23):5508. doi: 10.3390/cancers15235508. Cancers (Basel). 2023. PMID: 38067212 Free PMC article.
-
Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma.Mol Cancer Ther. 2015 Jun;14(6):1286-1294. doi: 10.1158/1535-7163.MCT-14-0774-T. Epub 2015 Mar 30. Mol Cancer Ther. 2015. PMID: 25824336 Free PMC article.
-
Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches.Int J Mol Sci. 2018 Dec 29;20(1):120. doi: 10.3390/ijms20010120. Int J Mol Sci. 2018. PMID: 30597997 Free PMC article. Review.
-
Small-molecule inhibitors of the Myc oncoprotein.Biochim Biophys Acta. 2015 May;1849(5):525-43. doi: 10.1016/j.bbagrm.2014.03.005. Epub 2014 Mar 19. Biochim Biophys Acta. 2015. PMID: 24657798 Free PMC article. Review.
-
Targeting MYC-Regulated miRNAs to Combat Cancer.Genes Cancer. 2010 Jun;1(6):660-7. doi: 10.1177/1947601910377488. Genes Cancer. 2010. PMID: 21779463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources